Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,099 public trials 2,041 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

A Study of Polatuzumab Vedotin in Combination With Rituximab or Obinutuzumab, Cyclophosphamide, Doxorubicin, and Prednisone in Participants With B-Cell Non-Hodgkin's Lymphoma

NCT01992653

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Greeley, Colorado, United States
  • Washington University; Pediatrics St Louis, Missouri, United States
  • Northwest Cancer Specialists Portland, Oregon, United States
View Trial Details
Completed

A Phase 3 Study Comparing Oral Ixazomib Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma

NCT01564537

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • University of Arkansas Medical Sciences Little Rock, Arkansas, United States
  • Pacific Cancer Medical Center Inc Anaheim, California, United States
  • West Contra Costa Healthcare District Berkeley, California, United States
  • University of Florida Gainesville, Florida, United States
View all 24 locations
View Trial Details
Completed

A Phase II Study on Allogeneic Stem Cell Transplantation in Patients With Active Acute Leukemia

NCT01814488

Conditions
Acute Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • Azienda Ospedaliera SS Antonio e Biagio Alessandria, Italy
  • Policlinico Bari, Italy
  • Divisione di Ematologia - Ospedali Papa Giovanni XXIII Bergamo, Italy
  • Ospedale San Orsola Bologna, Italy
View all 30 locations
View Trial Details
Completed

Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant

NCT00354120

Conditions
Acute Myeloblastic Leukemia, Anemia, Anemia, Refractory, +28 more
Locations
  • Ematologia e Centro Trapianti Midollo Osseo - Ospedale IRCCS Casa Sollievo della Sofferenza San Giovanni Rotondo, Foggia, Italy
  • Divisione Ematologia - Ospedale "SS. Antonio, Biagio e Cesare Arrigo" Alessandria, Italy
  • Clinica di Ematologia - Ospedali Riuniti di Ancona Ancona, Italy
  • Divisione di Ematologia - Ospedali Riuniti Bergamo Bergamo, Italy
View all 22 locations
View Trial Details

Related conditions